Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: Munich
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Proteome Sciences PLC

+ Add to Watchlist


0.323 EUR 0.064 24.71%

As of 03:05:12 ET on 04/27/2015.

Snapshot for Proteome Sciences PLC (PI2)

Open: 0.315 Day's Range: 0.315 - 0.326 Volume: 0
Previous Close: 0.259 52wk Range: 0.238 - 0.647 1-Yr Rtn: -21.41%

Stock Chart for PI2

No chart data available.
  • PI2:GR 0.315
  • 1D
  • 1M
  • 1Y
Interactive PI2 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PI2

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (12/2014) -0.0160
Est. PEG Ratio -
Market Cap (M EUR) 69.16
Shares Outstanding (M) 214.11
30 Day Average Volume 42
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/29/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PI2

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for PI2

Proteome Sciences PLC is a medical diagnostic research and development company. The Company identifies certain protein markers which may be used to identify specific disease states, as well as develops associated diagnostic techniques. Proteome's research concentrates on proteins related to neurological diseases, neurodegeneration, cardiovascular, cancers, diabetes, and obesity.

Christopher D J PearceChairman/CEOIan H PikeChief Operating Officer
Malcolm WardCTO:London Research FacilityChee Gee SeeDir:Personalised Medicine
More Company Profile & Key Executives for PI2

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil